Australia’s therapeutic goods administration (TGA) has announced that reports on myocarditis and pericarditis cases following mRNA-based COVID-19 vaccines by Pfizer and Moderna are not necessary anymore and will no longer be provided.
Australia’s national drug authority says this is because the rates have stabilised.
